GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $5.65 million. The enterprise value is $1.03 million.

Market Cap	5.65M
Enterprise Value	1.03M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 8.93 million shares outstanding. The number of shares has increased by 4,890.31% in one year.

Current Share Class	8.93M
Shares Outstanding	8.93M
Shares Change (YoY)	+4,890.31%
Shares Change (QoQ)	+590.51%
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	1.54%
Float	8.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.87
P/TBV Ratio	1.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.10, with a Debt / Equity ratio of 0.04.

Current Ratio	3.10
Quick Ratio	2.77
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -280.72% and return on invested capital (ROIC) is -171.75%.

Return on Equity (ROE)	-280.72%
Return on Assets (ROA)	-105.28%
Return on Invested Capital (ROIC)	-171.75%
Return on Capital Employed (ROCE)	-221.88%
Revenue Per Employee	n/a
Profits Per Employee	-$2.07M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-98.31%
50-Day Moving Average	0.74
200-Day Moving Average	1.76
Relative Strength Index (RSI)	39.77
Average Volume (20 Days)	171,187

Short Selling Information

The latest short interest is 344,982, so 3.86% of the outstanding shares have been sold short.

Short Interest	344,982
Short Previous Month	272,751
Short % of Shares Out	3.86%
Short % of Float	3.87%
Short Ratio (days to cover)	0.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.31M
Pretax Income	-12.77M
Net Income	-8.26M
EBITDA	-8.30M
EBIT	-8.31M
Earnings Per Share (EPS)	-$7.90

Full Income Statement

Balance Sheet

The company has $4.75 million in cash and $131,000 in debt, giving a net cash position of $4.62 million or $0.52 per share.

Cash & Cash Equivalents	4.75M
Total Debt	131,000
Net Cash	4.62M
Net Cash Per Share	$0.52
Equity (Book Value)	3.66M
Book Value Per Share	0.73
Working Capital	3.61M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.17M
Capital Expenditures	n/a
Free Cash Flow	-12.17M
FCF Per Share	-$1.36

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,890.31%
Shareholder Yield	-4,890.31%
Earnings Yield	-146.35%
FCF Yield	-215.59%

Analyst Forecast

The average price target for GRI Bio is $11.50, which is 1,719.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.50
Price Target Difference	1,719.62%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-75.67%

Stock Forecasts

Stock Splits

The last stock split was on June 18, 2024. It was a reverse split with a ratio of 0.0769231:1.

Last Split Date	Jun 18, 2024
Split Type	Reverse
Split Ratio	0.0769231:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1